Sign in →

Test Code IODCU Iodine/Creatinine Ratio, Random, Urine


Ordering Guidance


Due to the significant variation in the rate of secretion over the course of a day, a 24-hour collection is preferred. For more information see UIOD / Iodine, 24 Hour, Urine.



Specimen Required


Patient Preparation: High concentrations of gadolinium and iodine are known to interfere with most metal tests. If either gadolinium- or iodine-containing contrast media has been administered, wait a minimum of 96 hours before starting collection.

Supplies: Urine Tubes, 10 mL (T068)

Collection Container/Tube: Clean, plastic urine collection container

Submission Container/Tube: Plastic, 10-mL urine tube or a clean, plastic aliquot container with no metal cap or glued insert

Specimen Volume: 3 mL

Collection Instructions:

1. Collect a random urine specimen.

2. See Metals Analysis Specimen Collection and Transport for complete instructions.


Secondary ID

610708

Useful For

Assessment of iodine toxicity or recent iodine exposure using a random urine collection

 

Monitoring iodine excretion rate as index of replacement therapy

Profile Information

Test ID Reporting Name Available Separately Always Performed
IODC Iodine/Creat Ratio, U No Yes
CRETR Creatinine, Random, U No Yes

Method Name

IODC: Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

CRETR: Enzymatic Colorimetric Assay

Reporting Name

Iodine/Creat Ratio, Random, U

Specimen Type

Urine

Specimen Minimum Volume

2 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Urine Refrigerated (preferred) 30 days
  Frozen  30 days
  Ambient  14 days

Reject Due To

  All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.

Clinical Information

Iodine is an essential element for thyroid hormone production.

 

The measurement of urinary iodine is preferred for assessment of toxicity, recent exposure, and monitoring iodine excretion rate as an index of replacement therapy.

Reference Values

0-17 years: Not established

≥18 years: <584 mcg/g creatinine

Interpretation

Measurement of urinary iodine excretion provides the best index of dietary iodine intake and deficiency is generally indicated when the concentrations are below 100 mcg/L. For deficiency, 10 repeat random urines are recommended.

 

World Healthcare Organization (WHO) Criteria for Assessing Iodine Status

 

Children older than 6 years and adults

Median urinary iodine (mcg/L)

Iodine intake

Iodine status

<20

Insufficient

Severe deficiency

20-49

Insufficient

Moderate deficiency

50-99

Insufficient

Mild deficiency

100-199

Adequate

Adequate nutrition

200-299

Above requirements

May pose a slight risk of more than adequate

>299

Excessive

Risk of adverse health consequences

 

Pregnant women

Median urinary iodine (mcg/L)

Iodine intake

<150

Insufficient

150-249

Adequate

250-499

Above requirements

>499

Excessive

 

Lactating women and children younger than 2 years

Median urinary iodine (mcg/L)

Iodine intake

<100

Insufficient

>99

Adequate

Cautions

Administration of iodine-based contrast media and drugs containing iodine, such as amiodarone, will yield elevated results.

Clinical Reference

1. Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier; 2023

2. Knudsen N, Christiansen E, Brandt-Christensen M, Nygaard B, Perrild H. Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values. Eur J Clin Nutr. 2000;54(4):361-363

3. Liberman CS, Pino SC, Fang SL, Braverman LE, Emerson CH. Circulating iodine concentrations during and after pregnancy. J Clin Endocrinol Metab. 1998;83(10):3545-3549

4. Pfeiffer CM, Sternberg MR, Schleicher RL, et al. CDC's Second National Report on Biochemical Indicators of Diet and Nutrition in the US Population is a valuable tool for researchers and policy makers. J Nutr. 2013;143(6):938S-947S

5. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry: Toxicological Profile for Iodine. HHS; 2004. Accessed June 29, 2023. Available at www.atsdr.cdc.gov/ToxProfiles/tp158.pdf

6. Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol. 2014;10(3):136-142. doi:10.1038/nrendo.2013.251

7. Beckford K, Grimes CA, Margerison C, et al. A systematic review and meta-analysis of 24-h urinary output of children and adolescents: impact on the assessment of iodine status using urinary biomarkers. Eur J Nutr. 2020;59(7):3113-3131. doi:10.1007/s00394-019-02151-w

Method Description

The metal of interest is analyzed by inductively coupled plasma mass spectrometry.(Unpublished Mayo method)

Day(s) Performed

Tuesday, Friday

Report Available

2 to 5 days

Specimen Retention Time

14 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

83789

82570

LOINC Code Information

Test ID Test Order Name Order LOINC Value
IODCU Iodine/Creat Ratio, Random, U 55928-6

 

Result ID Test Result Name Result LOINC Value
CRETR Creatinine, Random, U 2161-8
614424 Iodine Concentration Interpretation 77202-0
614370 Iodine Concentration 2495-0
610709 Iodine/Creat Ratio, U 55928-6